Loading...
Sonoma Pharmaceuticals, Inc.
SNOA•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.67
$0.47(14.56%)
Sonoma Pharmaceuticals, Inc. (SNOA) Financial Performance & Statements
Review Sonoma Pharmaceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-4.05%
↓ 4.05%
Operating Income Growth
-2.87%
↓ 2.87%
Net Income Growth
6.13%
↑ 6.13%
Operating Cash Flow Growth
61.02%
↑ 61.02%
Operating Margin
-25.97%
↓ 25.97%
Gross Margin
38.25%
↑ 38.25%
Net Profit Margin
-24.20%
↓ 24.20%
ROE
-70.52%
↓ 70.52%
ROIC
-38.66%
↓ 38.66%
Sonoma Pharmaceuticals, Inc. (SNOA) Financial Statements
Explore quarterly and annual reports for Sonoma Pharmaceuticals, Inc. stock.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $3.56M | $3.58M | $3.39M | $3.44M |
| Cost of Revenue | $2.29M | $2.22M | $2.08M | $2.35M |
| Gross Profit | $1.27M | $1.36M | $1.31M | $1.09M |
| Gross Profit Ratio | $0.36 | $0.38 | $0.39 | $0.32 |
| R&D Expenses | $427000.00 | $506000.00 | $470000.00 | $409000.00 |
| SG&A Expenses | $1.87M | $1.71M | $2.009M | $2.09M |
| Operating Expenses | $2.30M | $2.21M | $2.48M | $2.50M |
| Total Costs & Expenses | $4.59M | $4.43M | $4.56M | $4.85M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $33000.00 | $35000.00 | $39000.00 | $41000.00 |
| EBITDA | -$998000.00 | -$815000.00 | -$1.13M | -$1.37M |
| EBITDA Ratio | -$0.28 | -$0.23 | -$0.33 | -$0.40 |
| Operating Income | -$1.03M | -$850000.00 | -$1.17M | -$1.41M |
| Operating Income Ratio | -$0.29 | -$0.24 | -$0.35 | -$0.41 |
| Other Income/Expenses (Net) | $112000.00 | $387000.00 | $176000.00 | $50000.00 |
| Income Before Tax | -$919000.00 | -$463000.00 | -$997000.00 | -$1.36M |
| Income Before Tax Ratio | -$0.26 | -$0.13 | -$0.29 | -$0.40 |
| Income Tax Expense | $9000.00 | $147000.00 | $146000.00 | -$292000.00 |
| Net Income | -$928000.00 | -$610000.00 | -$1.14M | -$1.07M |
| Net Income Ratio | -$0.26 | -$0.17 | -$0.34 | -$0.31 |
| EPS | -$0.63 | -$0.59 | -$1.34 | -$1.37 |
| Diluted EPS | -$0.63 | -$0.59 | -$1.34 | -$1.37 |
| Weighted Avg Shares Outstanding | $1.46M | $1.03M | $851450.00 | $780371.00 |
| Weighted Avg Shares Outstanding (Diluted) | $1.46M | $1.03M | $851450.00 | $780371.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan